A 28-year-old woman from rural Uttar Pradesh presents with a 10-day history of high-grade fever (39–40°C), headache, and abdominal pain. She reports constipation for the past 3 days. On examination, she is toxic-looking with a relative bradycardia (pulse 88/min despite fever). Her abdomen is soft with mild hepatosplenomegaly. Blood culture is pending. A Widal test shows O antigen titre of 1:320 and H antigen titre of 1:160. What is the most appropriate next step in management?

Explanation

## Clinical Diagnosis and Management of Enteric Fever ### Recognition of Enteric Fever **Key Point:** The clinical triad of fever, headache, and abdominal pain with relative bradycardia in a patient from an endemic region is classic for enteric fever (typhoid fever). **Clinical Pearl:** Relative bradycardia—a paradoxically slow pulse despite high fever—is a hallmark finding in enteric fever and helps distinguish it from other acute bacterial infections. ### Diagnostic Interpretation The Widal test shows: - O antigen titre 1:320 (diagnostic threshold typically ≥1:160) - H antigen titre 1:160 (at or near diagnostic threshold) **High-Yield:** In endemic areas, a single Widal with O antigen ≥1:160 in the appropriate clinical context is sufficient for diagnosis; blood culture confirmation is ideal but should NOT delay treatment in a toxic patient. ### Treatment Rationale **Key Point:** Empirical antibiotic therapy must begin immediately in suspected enteric fever because: 1. The patient is in the second week (high risk of complications) 2. Clinical and serological evidence is strong 3. Delaying treatment increases risk of perforation and mortality 4. Ceftriaxone is the current first-line agent for uncomplicated enteric fever in India (fluoroquinolone resistance is now widespread) **Mnemonic: CFTR** — **C**eftriaxone (or **C**efixime), **F**luoroquinolones (now resistant), **T**rimethoprim-sulfamethoxazole (resistance common), **R**eserve chloramphenicol ### Why Ceftriaxone Now? - Excellent CNS penetration (relevant if cerebritis develops) - Covers both susceptible and moderately resistant *Salmonella typhi* - Oral fluoroquinolones (once first-line) are no longer recommended due to widespread resistance in South Asia - Chloramphenicol is now reserved for severe cases or meningitis due to resistance emergence ### Timing of Blood Culture Blood culture is ideal but should NOT delay empirical therapy in a clinically toxic patient. The diagnosis is already supported by clinical presentation and Widal serology. ## Differential Considerations | Feature | Enteric Fever | Malaria | Leptospirosis | |---------|---------------|---------|---------------| | Relative bradycardia | Yes (classic) | No (tachycardia) | No (tachycardia) | | Constipation | Common | Diarrhea typical | Variable | | Hepatosplenomegaly | Yes | Yes | Yes | | Widal positive | Yes | No | No | | Rash | Rose spots (rare) | None | None | **Clinical Pearl:** The combination of relative bradycardia + constipation + positive Widal in an endemic region makes enteric fever the overwhelming diagnosis.